UTHSC and Regional One Health Collaborate to Bring Promising COVID-19 Treatment Clinical Trial to Memphis
|
The University of Tennessee Health Science Center and Regional One Health today are announcing that they are partnering on a clinical trial program including two late-stage clinical trials evaluating Regeneron’s REGN-COV2, the company’s investigational two-antibody cocktail for the treatment and prevention of COVID-19. Leading the efforts are John Jefferies, MD, MPH, FAAP, FACC, FAHA, FHFSA,… Read More